{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:58:12Z","timestamp":1779231492195,"version":"3.51.4"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.sult.2013.09.005","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T05:53:20Z","timestamp":1397800400000},"page":"97-117","source":"Crossref","is-referenced-by-count":40,"title":["Toxic Leukoencephalopathies, Including Drug, Medication, Environmental, and Radiation-Induced Encephalopathic Syndromes"],"prefix":"10.1053","volume":"35","author":[{"given":"Carolina de Medeiros","family":"Rimkus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celi Santos","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia da Costa","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Tavares","family":"Lucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.sult.2013.09.005_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM200108093450606","article-title":"Toxic leukoencephalopathy","volume":"345","author":"Filley","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2013.09.005_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1081\/CLT-100108512","article-title":"Neurotoxicology of the brain barrier system: New implications","volume":"39","author":"Zheng","year":"2001","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1053\/j.sult.2013.09.005_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03033362","article-title":"Neurotoxins and neurotoxicity mechanisms. An overview","volume":"10","author":"Segura-Aguilar","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1053\/j.sult.2013.09.005_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2214\/AJR.08.1176","article-title":"Acute toxic leukoencephalopathy: Potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging","volume":"193","author":"McKinney","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1528-1157.2001.28600.x","article-title":"Vigabatrin visual toxicity: Evolution and dose dependence","volume":"42","author":"Malmgren","year":"2001","journal-title":"Epilepsia"},{"key":"10.1053\/j.sult.2013.09.005_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00234-007-0210-8","article-title":"Methanol poisoning: Acute MR and CT findings in nine patients","volume":"49","author":"Sefidbakht","year":"2007","journal-title":"Neuroradiology"},{"key":"10.1053\/j.sult.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2214\/ajr.180.3.1800847","article-title":"Neuroimaging features of heroin inhalation toxicity: \u201cChasing the dragon\u201d","volume":"180","author":"Keogh","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2214\/AJR.08.2257","article-title":"Toxic and acquired metabolic encephalopathies: MRI appearance","volume":"193","author":"Sharma","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jns.2007.06.037","article-title":"Carbon monoxide intoxication: An updated review","volume":"262","author":"Prockop","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.sult.2013.09.005_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1259\/bjr\/61535842","article-title":"Chasing \u201cchasing the dragon\u201d with MRI: Leukoencephalopathy in drug abuse","volume":"78","author":"Bartlett","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1053\/j.sult.2013.09.005_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1148\/rg.274065103","article-title":"Radiology of recreational drug abuse","volume":"27","author":"Hagan","year":"2007","journal-title":"Radiographics"},{"key":"10.1053\/j.sult.2013.09.005_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1054\/bjoc.2001.2100","article-title":"Radiation induced CNS toxicity\u2014Molecular and cellular mechanisms","volume":"85","author":"Belka","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0733-8619(02)00031-2","article-title":"Neurologic complications of radiation therapy","volume":"21","author":"Cross","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1053\/j.sult.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(09)61299-X","article-title":"CNS complications of radiotherapy and chemotherapy","volume":"374","author":"Soussain","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.sult.2013.09.005_bib15","first-page":"45","article-title":"Radiation injury of the brain","volume":"12","author":"Valk","year":"1991","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12094-007-0108-2","article-title":"Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases","volume":"9","author":"Conill","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2012.00073","article-title":"Radiation-induced brain injury: A review","volume":"2","author":"Greene-Schloesser","year":"2012","journal-title":"Front Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"19150","DOI":"10.1073\/pnas.0909293106","article-title":"Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells","volume":"106","author":"Acharya","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.sult.2013.09.005_bib19","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1158\/0008-5472.CAN-11-0027","article-title":"Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction","volume":"71","author":"Acharya","year":"2011","journal-title":"Cancer Res"},{"key":"10.1053\/j.sult.2013.09.005_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3727\/096368912X640565","article-title":"Comparing the functional consequences of human stem cell transplantation in the irradiated rat brain","volume":"22","author":"Acharya","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1053\/j.sult.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/0004-282X20130033","article-title":"SMART syndrome: A late reversible complication of radiotherapy","volume":"71","author":"Diniz","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1053\/j.sult.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/0333102410388436","article-title":"Neurocognitive recovery in SMART syndrome: A case report","volume":"31","author":"Bradshaw","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1053\/j.sult.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.canrad.2012.03.009","article-title":"SMART syndrome: Case report of a rare complication after cerebral radiation therapy","volume":"16","author":"Truntzer","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1053\/j.sult.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00415-010-5892-x","article-title":"SMART syndrome: A late reversible complication after radiation therapy for brain tumours","volume":"258","author":"Kerklaan","year":"2011","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/RLU.0b013e3181e4db6f","article-title":"Normal cerebrovascular reactivity in stroke-like migraine attacks after radiation therapy syndrome","volume":"35","author":"Farid","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.sult.2013.09.005_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/neuonc\/5.2.121","article-title":"Reversible, strokelike migraine attacks in patients with previous radiation therapy","volume":"5","author":"Bartleson","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1468-2982.2006.01184.x","article-title":"SMART: Stroke-like migraine attacks after radiation therapy","volume":"26","author":"Black","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1053\/j.sult.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1212\/01.wnl.0000204178.65221.b8","article-title":"Prolonged but reversible migraine-like episodes long after cranial irradiation","volume":"66","author":"Partap","year":"2006","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2013.09.005_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/hbm.21033","article-title":"Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients","volume":"32","author":"Deprez","year":"2011","journal-title":"Hum Brain Mapp"},{"key":"10.1053\/j.sult.2013.09.005_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.2011.36.8571","article-title":"Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning","volume":"30","author":"Deprez","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/1040-8428(93)90006-P","article-title":"Neurotoxicity of antineoplastic agents","volume":"14","author":"Hussain","year":"1993","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.sult.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM197407112910205","article-title":"Neurotoxicity of commonly used antineoplastic agents. 1","volume":"291","author":"Weiss","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2013.09.005_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJM197407182910305","article-title":"Neurotoxicity of commonly used antineoplastic agents. 2","volume":"291","author":"Weiss","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2013.09.005_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00432-005-0070-8","article-title":"Short-term monitoring of cognitive functions before and during the first course of treatment","volume":"132","author":"Eberhardt","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1532-5415.2006.00732.x","article-title":"Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study","volume":"54","author":"Hurria","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/j.sult.2013.09.005_bib36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pon.742","article-title":"The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy","volume":"12","author":"Ahles","year":"2003","journal-title":"Psychooncology"},{"key":"10.1053\/j.sult.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.20.2.485","article-title":"Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma","volume":"20","author":"Ahles","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1053\/j.sult.2013.09.005_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.bjc.6603029","article-title":"A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer","volume":"94","author":"Jenkins","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-010-1088-4","article-title":"Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study","volume":"123","author":"McDonald","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.sult.2013.09.005_bib41","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/hbm.21422","article-title":"Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging","volume":"33","author":"de Ruiter","year":"2012","journal-title":"Hum Brain Mapp"},{"key":"10.1053\/j.sult.2013.09.005_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.22368","article-title":"Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy","volume":"109","author":"Inagaki","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib43","first-page":"1199","article-title":"Posterior reversible encephalopathy syndrome: Utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions","volume":"21","author":"Casey","year":"2000","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2214\/AJR.07.2024","article-title":"Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings","volume":"189","author":"McKinney","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2013.09.005_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2214\/AJR.08.1176","article-title":"Acute toxic leukoencephalopathy: Potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging","volume":"193","author":"McKinney","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2013.09.005_bib46","first-page":"1686","article-title":"Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children","volume":"26","author":"Fisher","year":"2005","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib47","first-page":"2371","article-title":"A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation","volume":"26","author":"Reddick","year":"2005","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12032-011-9839-6","article-title":"Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients","volume":"29","author":"Sun","year":"2012","journal-title":"Med Oncol"},{"issue":"1","key":"10.1053\/j.sult.2013.09.005_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12032-012-0451-1","article-title":"The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: Phase II trial","volume":"30","author":"Anter","year":"2013","journal-title":"Med Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib50","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1158\/1535-7163.MCT-07-0071","article-title":"Bevacizumab plus 5-fluorouracil induce growth suppression in the CWR-22 and CWR-22R prostate cancer xenografts","volume":"6","author":"Hung","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.sult.2013.09.005_bib51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/bjc.1997.79","article-title":"High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy","volume":"75","author":"Yeh","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000320032","article-title":"Genetic polymorphisms associated with 5-fluorouracil-induced neurotoxicity","volume":"56","author":"Kim","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1053\/j.sult.2013.09.005_bib53","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1200\/JCO.1994.12.11.2248","article-title":"Population study of dihydropyrimidine dehydrogenase in cancer-patients","volume":"12","author":"Etienne","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clcc.2012.01.004","article-title":"Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion","volume":"11","author":"Li","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib55","first-page":"477","article-title":"Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency","volume":"2","author":"Takimoto","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.sult.2013.09.005_bib56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1440-1673.2006.01602.x","article-title":"Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity","volume":"50","author":"Lucato","year":"2006","journal-title":"Australas Radiol"},{"key":"10.1053\/j.sult.2013.09.005_bib57","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.mao.0000194815.15298.8b","article-title":"Reversible impairment of auditory callosal pathway in 5-fluorouracil-induced leukoencephalopathy: Parallel changes in function and imaging","volume":"27","author":"Fujimoto","year":"2006","journal-title":"Otol Neurotol"},{"key":"10.1053\/j.sult.2013.09.005_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1034\/j.1600-0404.2002.01253.x","article-title":"Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy","volume":"106","author":"Tha","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/j.sult.2013.09.005_bib59","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.clineuro.2012.02.035","article-title":"MR imaging in the early stage of 5-fluorouracil-induced leukoencephalopathy: DWI, MR perfusion, and MR spectroscopy","volume":"114","author":"Bang","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1053\/j.sult.2013.09.005_bib60","first-page":"1735","article-title":"Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal-fluid and brain following intravenous-injection in a primate","volume":"33","author":"Bourke","year":"1973","journal-title":"Cancer Res"},{"key":"10.1053\/j.sult.2013.09.005_bib61","first-page":"4929","article-title":"Effect of intravenous dose and schedule on cerebrospinal-fluid pharmacokinetics of 5-fluorouracil in the monkey","volume":"44","author":"Kerr","year":"1984","journal-title":"Cancer Res"},{"key":"10.1053\/j.sult.2013.09.005_bib62","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1124\/dmd.110.032797","article-title":"Formation pathways of gamma-butyrolactone from the furan ring of tegafur during its conversion to 5-fluorouracil","volume":"38","author":"Yamamiya","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1053\/j.sult.2013.09.005_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004010050929","article-title":"Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative","volume":"96","author":"Ohara","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1053\/j.sult.2013.09.005_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00314079","article-title":"Subacute leukoencephalopathy induced by carmofur, a 5-fluorouracil derivative","volume":"234","author":"Kuzuhara","year":"1987","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00280-005-0159-4","article-title":"5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: Should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma","volume":"58","author":"Formica","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.sult.2013.09.005_bib66","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2169\/internalmedicine.31.828","article-title":"Leukoencephalopathy induced by tegafur\u2014Serial studies of somatosensory evoked-potentials and cerebrospinal-fluid","volume":"31","author":"Hayashi","year":"1992","journal-title":"Intern Med"},{"key":"10.1053\/j.sult.2013.09.005_bib67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/j.1875-9114.1996.tb02951.x","article-title":"Acute encephalopathy attributed to 5-FU","volume":"16","author":"Langer","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.sult.2013.09.005_bib68","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3340\/jkns.2011.50.4.304","article-title":"Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia","volume":"50","author":"Kim","year":"2011","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1053\/j.sult.2013.09.005_bib69","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00247-005-0015-z","article-title":"Reversible acute methotrexate leukoencephalopathy: Atypical brain MR imaging features","volume":"36","author":"Ziereisen","year":"2006","journal-title":"Pediatr Radiol"},{"key":"10.1053\/j.sult.2013.09.005_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0887-8994(01)00376-9","article-title":"Methotrexate leukoencephalopathy presenting as Kluver-Bucy syndrome and uncinate seizures","volume":"26","author":"Antunes","year":"2002","journal-title":"Pediatr Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib71","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2169\/internalmedicine.50.5552","article-title":"Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis","volume":"50","author":"Matsuda","year":"2011","journal-title":"Intern Med"},{"key":"10.1053\/j.sult.2013.09.005_bib72","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.120152","article-title":"Reversible leukoencephalopathy after oral methotrexate","volume":"39","author":"Koppen","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1053\/j.sult.2013.09.005_bib73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/0973-1482.98993","article-title":"Methotrexate-induced acute toxic leukoencephalopathy","volume":"8","author":"Salkade","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"10.1053\/j.sult.2013.09.005_bib74","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00415-011-6053-6","article-title":"Methotrexate leukoencephalopathy mimics acute progressive stroke","volume":"258","author":"Tanaka","year":"2011","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s002470050299","article-title":"Pure methotrexate encephalopathy presenting with seizures: CT and MRI features","volume":"28","author":"Lovblad","year":"1998","journal-title":"Pediatr Radiol"},{"key":"10.1053\/j.sult.2013.09.005_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000077573","article-title":"Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid","volume":"111","author":"Jaksic","year":"2004","journal-title":"Acta Haematol"},{"key":"10.1053\/j.sult.2013.09.005_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08880019009034321","article-title":"Methotrexate induced leukoencephalopathy is treatable with high-dose folinic acid\u2014A case-report and analysis of the literature","volume":"7","author":"Cohen","year":"1990","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1991.253","article-title":"Fludarabine phosphate for the treatment of low-grade lymphoid malignancy","volume":"64","author":"Whelan","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1053\/j.sult.2013.09.005_bib79","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2010.04.003","article-title":"Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation","volume":"17","author":"Beitinjaneh","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.sult.2013.09.005_bib80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00280-002-0443-5","article-title":"Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: A CALGB (9011) coordinated intergroup study","volume":"50","author":"Martell","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.sult.2013.09.005_bib81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.tpj.6500303","article-title":"Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)","volume":"5","author":"Badagnani","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1053\/j.sult.2013.09.005_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.1991.9.1.175","article-title":"Fludarabine phosphate\u2014A synthetic purine antimetabolite with significant activity against lymphoid malignancies","volume":"9","author":"Chun","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2013.09.005_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNO.0b013e3181ce8087","article-title":"Clinical and imaging features of fludarabine neurotoxicity","volume":"30","author":"Lee","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"10.1053\/j.sult.2013.09.005_bib84","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib85","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002779900149","article-title":"Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia","volume":"79","author":"Cid","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1053\/j.sult.2013.09.005_bib86","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1080\/1042819031000116625","article-title":"Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy","volume":"44","author":"Kiewe","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.sult.2013.09.005_bib87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neurad.2011.12.005","article-title":"Gadolinium enhancement in brain magnetic resonance imaging in progressive multifocal leukoencephalopathy after natalizumab monotherapy: Is it really atypical?","volume":"49","author":"Arnaud","year":"2012","journal-title":"J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainresrev.2008.03.002","article-title":"Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs","volume":"58","author":"Cunha-Oliveira","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1053\/j.sult.2013.09.005_bib89","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(82)90101-5","article-title":"Leucoencephalopathy after inhaling \u201cheroin\u201d pyrolysate","volume":"2","author":"Wolters","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/j.sult.2013.09.005_bib90","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08958378.2012.684364","article-title":"Clinical presentation and management in acute toluene intoxication: A case series","volume":"24","author":"Camara-Lemarroy","year":"2012","journal-title":"Inhal Toxicol"},{"key":"10.1053\/j.sult.2013.09.005_bib91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1353-1131(03)00035-X","article-title":"Solvent abuse-related toluene leukoencephalopathy","volume":"10","author":"Fornazzari","year":"2003","journal-title":"J Clin Forensic Med"},{"key":"10.1053\/j.sult.2013.09.005_bib92","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0730-725X(03)00175-9","article-title":"Single-voxel proton MR spectroscopy in toluene abuse","volume":"21","author":"Aydin","year":"2003","journal-title":"Magn Reson Imaging"},{"key":"10.1053\/j.sult.2013.09.005_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: A review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2013.09.005_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/clin.1993.1122","article-title":"Mechanisms of action of cyclosporine: Considerations for the treatment of autoimmune diseases","volume":"68","author":"Hess","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/j.sult.2013.09.005_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-5699(93)90061-O","article-title":"The mechanisms of action of cyclosporin A in the treatment of psoriasis","volume":"14","author":"Wong","year":"1993","journal-title":"Immunol Today"},{"key":"10.1053\/j.sult.2013.09.005_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1582-4934.2004.tb00321.x","article-title":"Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease","volume":"8","author":"Kountouras","year":"2004","journal-title":"J Cell Mol Med"},{"key":"10.1053\/j.sult.2013.09.005_bib97","first-page":"393","article-title":"Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin","volume":"8","author":"Reece","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.sult.2013.09.005_bib98","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/WNL.45.11.1962","article-title":"Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression","volume":"45","author":"Wijdicks","year":"1995","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2013.09.005_bib99","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0025-6196(12)65348-8","article-title":"Cyclosporine: A review and its specific use in liver transplantation","volume":"64","author":"de Groen","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.sult.2013.09.005_bib100","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0140-6736(92)90707-A","article-title":"Cyclosporin leukoencephalopathy induced by intravenous lipid solution","volume":"339","author":"De Klippel","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.sult.2013.09.005_bib101","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00234-004-1258-3","article-title":"Diffusion MR findings in cyclosporin-A induced encephalopathy","volume":"46","author":"Aydin","year":"2004","journal-title":"Neuroradiology"},{"key":"10.1053\/j.sult.2013.09.005_bib102","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","article-title":"Metronidazole-induced central nervous system toxicity: A systematic review","volume":"34","author":"Kuriyama","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/j.sult.2013.09.005_bib103","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3174\/ajnr.A0655","article-title":"MR imaging of metronidazole-induced encephalopathy: Lesion distribution and diffusion-weighted imaging findings","volume":"28","author":"Kim","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib104","first-page":"1615","article-title":"MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity","volume":"24","author":"Heaney","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.1.6061.607","article-title":"Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery","volume":"1","author":"Willis","year":"1977","journal-title":"Br Med J"},{"key":"10.1053\/j.sult.2013.09.005_bib106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/003693307702200213","article-title":"Metronidazole in anaerobic infections","volume":"22","author":"Willis","year":"1977","journal-title":"Scott Med J"},{"key":"10.1053\/j.sult.2013.09.005_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200201033460117","article-title":"Reversible metronidazole-induced lesions of the cerebellar dentate nuclei","volume":"346","author":"Woodruff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2013.09.005_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nurt.2006.11.008","article-title":"Vigabatrin","volume":"4","author":"Wheless","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1053\/j.sult.2013.09.005_bib109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1053\/j.sult.2013.09.005_bib110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1053\/j.sult.2013.09.005_bib111","doi-asserted-by":"crossref","first-page":"e43889","DOI":"10.1371\/journal.pone.0043889","article-title":"Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors","volume":"7","author":"Yang","year":"2012","journal-title":"PloS One"},{"key":"10.1053\/j.sult.2013.09.005_bib112","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.57.2.196","article-title":"Visual field constriction: Accumulation of vigabatrin but not tiagabine in the retina","volume":"57","author":"Sills","year":"2001","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2013.09.005_bib113","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.44.10.1944","article-title":"MRI monitoring of vigabatrin-induced intramyelinic edema in dogs","volume":"44","author":"Weiss","year":"1994","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2013.09.005_bib114","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1528-1167.2010.02564.x","article-title":"Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms","volume":"51","author":"Dracopoulos","year":"2010","journal-title":"Epilepsia"},{"key":"10.1053\/j.sult.2013.09.005_bib115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.296.6615.77","article-title":"Carbon monoxide poisoning","volume":"296","author":"Meredith","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.sult.2013.09.005_bib116","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/014107680109400604","article-title":"Carbon monoxide poisoning","volume":"94","author":"Blumenthal","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1053\/j.sult.2013.09.005_bib117","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1073\/pnas.97.3.1305","article-title":"Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide","volume":"97","author":"Thom","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.sult.2013.09.005_bib118","first-page":"1475","article-title":"Acute carbon monoxide poisoning: Diffusion MR imaging findings","volume":"24","author":"Sener","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib119","first-page":"452","article-title":"CT and MR imaging findings in methanol intoxication","volume":"27","author":"Blanco","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9343(80)90113-8","article-title":"Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis","volume":"68","author":"McMartin","year":"1980","journal-title":"Am J Med"},{"key":"10.1053\/j.sult.2013.09.005_bib121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5144\/0256-4947.2012.26.5.1114","article-title":"Methanol poisoning: Characteristic MRI findings","volume":"33","author":"Jain","year":"2013","journal-title":"Ann Saudi Med"},{"key":"10.1053\/j.sult.2013.09.005_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2013.05.003","article-title":"Exposure to As, Cd and Pb-mixture impairs myelin and axon development in rat brain, optic nerve and retina","author":"Rai","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1053\/j.sult.2013.09.005_bib123","first-page":"902","article-title":"Pre- and posttreatment MR imaging findings in lead encephalopathy","volume":"27","author":"Atre","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1179\/1743132812Y.0000000115","article-title":"Adult lead encephalopathy","volume":"35","author":"de Souza","year":"2013","journal-title":"Neurol Res"},{"key":"10.1053\/j.sult.2013.09.005_bib125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1590\/S0004-282X2008000400031","article-title":"Choreoathetosis secondary to lead toxicity","volume":"66","author":"Spitz","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1053\/j.sult.2013.09.005_bib126","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00234-007-0235-z","article-title":"Reversible focal splenial lesions","volume":"49","author":"Gallucci","year":"2007","journal-title":"Neuroradiology"},{"key":"10.1053\/j.sult.2013.09.005_bib127","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000144274.12174.CB","article-title":"Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion","volume":"63","author":"Tada","year":"2004","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2013.09.005_bib128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-2982.2008.01759.x","article-title":"Reversible focal splenial lesions in facial pain patients treated with antiepileptic drugs: Case report and review of the literature","volume":"29","author":"Ruscheweyh","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1053\/j.sult.2013.09.005_bib129","first-page":"836","article-title":"Widening spectrum of a reversible splenial lesion with transiently reduced diffusion","volume":"27","author":"Takanashi","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2006.03.015","article-title":"Reversible restricted diffusion of entire corpus callosum","volume":"247","author":"Takanashi","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.sult.2013.09.005_bib131","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jocn.2011.09.017","article-title":"Reversible splenial lesion in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia","volume":"19","author":"Mori","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1053\/j.sult.2013.09.005_bib132","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00234-006-0116-x","article-title":"Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients","volume":"48","author":"da Rocha","year":"2006","journal-title":"Neuroradiology"},{"key":"10.1053\/j.sult.2013.09.005_bib133","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.braindev.2008.10.005","article-title":"A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible. A case report","volume":"31","author":"Hashimoto","year":"2009","journal-title":"Brain Dev"},{"key":"10.1053\/j.sult.2013.09.005_bib134","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1016\/j.ijid.2012.11.003","article-title":"Measles encephalitis the return: Mild encephalitis with reversible splenial lesion","volume":"17","author":"Melenotte","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1053\/j.sult.2013.09.005_bib135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1552-6569.2008.00279.x","article-title":"Reversible splenial lesion syndrome (RESLES): What's in a name?","volume":"21","author":"Garcia-Monco","year":"2011","journal-title":"J Neuroimaging"},{"key":"10.1053\/j.sult.2013.09.005_bib136","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004728-199805000-00026","article-title":"Marchiafava-Bignami disease: Reversibility of neuroimaging abnormality","volume":"22","author":"Gass","year":"1998","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.sult.2013.09.005_bib137","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1051228405279037","article-title":"Restricted diffusion of the splenium in acute Wernicke's encephalopathy","volume":"15","author":"Loh","year":"2005","journal-title":"J Neuroimaging"},{"key":"10.1053\/j.sult.2013.09.005_bib138","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2011.11.022","article-title":"Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS)","volume":"315","author":"Takanashi","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.sult.2013.09.005_bib139","first-page":"1144","article-title":"Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy","volume":"19","author":"Ogura","year":"1998","journal-title":"Am J Neuroradiol"},{"key":"10.1053\/j.sult.2013.09.005_bib140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0303-8467(00)00079-2","article-title":"Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury","volume":"102","author":"Takayama","year":"2000","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1053\/j.sult.2013.09.005_bib141","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/01.WNL.0000103440.64964.86","article-title":"Reversible abnormalities of DWI in high-altitude cerebral edema","volume":"62","author":"Wong","year":"2004","journal-title":"Neurology"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217113000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217113000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:02:04Z","timestamp":1716681724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217113000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0887217113000863"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2013.09.005","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}